Quiz questions. Idiopathic leukoplakia, tobacoco-induced leukoplakia, frictional keratosis, plaque lichen planus, candidal leukoplakia (chronic hyperplastic leukoplakia), squamous cell carcinoma, lichenoid reaction to drug or amalgam, or oral hairy leukoplakia.

C. Healy

2011-08-01

Abstract:

What problem does this paper attempt to address?

Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children

Lyudmyla Kompaniyets,Nickolas T Agathis,Jennifer M Nelson,Leigh Ellyn Preston,Jean Y Ko,Brook Belay,Audrey F Pennington,Melissa L Danielson,Carla L DeSisto,Jennifer R Chevinsky,Lyna Z Schieber,Hussain Yusuf,James Baggs,William R Mac Kenzie,Karen K Wong,Tegan K Boehmer,Adi V Gundlapalli,Alyson B Goodman

DOI: https://doi.org/10.1001/jamanetworkopen.2021.11182

2021-06-01

Abstract:Importance: Information on underlying conditions and severe COVID-19 illness among children is limited. Objective: To examine the risk of severe COVID-19 illness among children associated with underlying medical conditions and medical complexity. Design, setting, and participants: This cross-sectional study included patients aged 18 years and younger with International Statistical Classification of Diseases, Tenth Revision, Clinical Modification code U07.1 (COVID-19) or B97.29 (other coronavirus) during an emergency department or inpatient encounter from March 2020 through January 2021. Data were collected from the Premier Healthcare Database Special COVID-19 Release, which included data from more than 800 US hospitals. Multivariable generalized linear models, controlling for patient and hospital characteristics, were used to estimate adjusted risk of severe COVID-19 illness associated with underlying medical conditions and medical complexity. Exposures: Underlying medical conditions and medical complexity (ie, presence of complex or noncomplex chronic disease). Main outcomes and measures: Hospitalization and severe illness when hospitalized (ie, combined outcome of intensive care unit admission, invasive mechanical ventilation, or death). Results: Among 43 465 patients with COVID-19 aged 18 years or younger, the median (interquartile range) age was 12 (4-16) years, 22 943 (52.8%) were female patients, and 12 491 (28.7%) had underlying medical conditions. The most common diagnosed conditions were asthma (4416 [10.2%]), neurodevelopmental disorders (1690 [3.9%]), anxiety and fear-related disorders (1374 [3.2%]), depressive disorders (1209 [2.8%]), and obesity (1071 [2.5%]). The strongest risk factors for hospitalization were type 1 diabetes (adjusted risk ratio [aRR], 4.60; 95% CI, 3.91-5.42) and obesity (aRR, 3.07; 95% CI, 2.66-3.54), and the strongest risk factors for severe COVID-19 illness were type 1 diabetes (aRR, 2.38; 95% CI, 2.06-2.76) and cardiac and circulatory congenital anomalies (aRR, 1.72; 95% CI, 1.48-1.99). Prematurity was a risk factor for severe COVID-19 illness among children younger than 2 years (aRR, 1.83; 95% CI, 1.47-2.29). Chronic and complex chronic disease were risk factors for hospitalization, with aRRs of 2.91 (95% CI, 2.63-3.23) and 7.86 (95% CI, 6.91-8.95), respectively, as well as for severe COVID-19 illness, with aRRs of 1.95 (95% CI, 1.69-2.26) and 2.86 (95% CI, 2.47-3.32), respectively. Conclusions and relevance: This cross-sectional study found a higher risk of severe COVID-19 illness among children with medical complexity and certain underlying conditions, such as type 1 diabetes, cardiac and circulatory congenital anomalies, and obesity. Health care practitioners could consider the potential need for close observation and cautious clinical management of children with these conditions and COVID-19.
Clinical Features and Outcomes of Pediatric and Adult Patients Hospitalized for Coronavirus Disease 2019: A Comparison Across Age Strata

Grace X Li,Komal Gopchandani,Noah Brazer,Ashley Tippett,Chris Choi,Hui-Mien Hsiao,Miriam Oseguera,Abiodun Foresythe,Sanchita Bhattacharya,Venice Servellita,Alicia Sotomayor Gonzalez,Jennifer K Spinler,Mark D Gonzalez,Dalia Gulick,Colleen Kraft,Vyjayanti Kasinathan,Yun F Wayne Wang,Jennifer Dien Bard,Pei Ying Chen,Jessica Flores-Vazquez,Audrey R Odom John,Paul J Planet,Sridevi Devaraj,Ananth V Annapragada,Ruth Ann Luna,Charles Y Chiu,Christina A Rostad

DOI: https://doi.org/10.1093/ofid/ofae443

2024-08-10

Abstract:Background: Coronavirus disease 2019 (COVID-19) continues to cause hospitalizations and severe disease in children and adults. Methods: This study compared the risk factors, symptoms, and outcomes of children and adults hospitalized for COVID-19 from March 2020 to May 2023 across age strata at 5 US sites participating in the Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence consortium. Eligible patients had an upper respiratory swab that tested positive for severe acute respiratory syndrome coronavirus 2 by nucleic acid amplification. Adjusted odds ratios (aOR) of clinical outcomes were determined for children versus adults, for pediatric age strata compared to adolescents (12-17 years), and for adult age strata compared to young adults (22-49 years). Results: Of 9101 patients in the Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence cohort, 1560 were hospitalized for COVID-19 as the primary reason. Compared to adults (22-105 years, n = 675), children (0-21 years, n = 885) were less commonly vaccinated (14.3% vs 34.5%), more commonly infected with the Omicron variant (49.5% vs 26.1%) and had fewer comorbidities (P < .001 for most comparisons), except for lung disease (P = .24). After adjusting for confounding variables, children had significantly lower odds of receiving supplemental oxygen (aOR, 0.57; 95% confidence interval, .35-.92) and death (aOR, 0.011; 95% confidence interval, <.01-.58) compa--red to adults. Among pediatric age strata, adolescents 12-17 years had the highest odds of receiving supplemental oxygen, high-flow oxygen, and ICU admission. Among adults, those 50-64 years had the highest odds of mechanical ventilation and ICU admission. Conclusions: Clinical outcomes of COVID-19 differed across pediatric and adult age strata. Adolescents experienced the most severe disease among children, whereas adults 50-64 years experienced the most severe disease among adults.
Educational strategies for overcoming health care disparities

D. Butler,J. Freedy

DOI: https://doi.org/10.1177/0091217417728458

2017-05-01

Abstract:In 2002, the Institute of Medicine (IOM) released a report, Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care which concluded that the quality of health care in the United States varied significantly with the racial background of patients, even when insurance, income, age, and severity of conditions were comparable. The findings verified that racial and ethnic minorities were less likely to receive routine medical care and more likely to receive lower quality services which contributed to poorer quality of life and greater disease burden. There is further evidence that health care disparities affect vulnerable populations regardless of race, including the homeless, the previously incarcerated, victims of abuse and those suffering from mental illness. The 37th Forum for Behavioral Science in Family Medicine which took place in Chicago, Illinois in Fall 2016 addressed the theme of reducing health care disparities and promoting multicultural practice in medical education. This special issue of the International Journal of Psychiatry and Medicine presents 10 articles drawn from the most highly rated presentations at the conference. Within the issue are descriptions of innovative, successful efforts by medical educators to reverse the systemic and personal factors which contribute to the failure of the US health care system to meet the needs of diverse patient groups. The insights that emerge can have a measurable impact on health care disparities; the proposed solutions will resonate with those who care for displaced, disenfranchised, and underserved patients around the world. To fully understand the dynamics underling disparities, readers should begin with the article, A Commitment to Health Equity: Reflections on Why; One Journey Toward How, by Jennifer Edgoose whose personal insights help frame disparities as the outcome of racism. She notes three forms of racism, the first of which is implicit and explicit bias, prejudice, and stereotyping by the provider,
Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives

Yi-Kan Sun,Can Wang,Pei-Quan Lin,Lei Hu,Jing Ye,Zhi-Gang Gao,Ru Lin,Hao-Min Li,Qiang Shu,Li-Su Huang,Lin-Hua Tan

DOI: https://doi.org/10.1007/s12519-023-00790-y

2024-01-01

World Journal of Pediatrics

Abstract:Background Coronavirus disease 2019 (COVID-19) tends to have mild presentations in children. However, severe and critical cases do arise in the pediatric population with debilitating systemic impacts and can be fatal at times, meriting further attention from clinicians. Meanwhile, the intricate interactions between the pathogen virulence factors and host defense mechanisms are believed to play indispensable roles in severe COVID-19 pathophysiology but remain incompletely understood. Data sources A comprehensive literature review was conducted for pertinent publications by reviewers independently using the PubMed, Embase, and Wanfang databases. Searched keywords included “COVID-19 in children”, “severe pediatric COVID-19”, and “critical illness in children with COVID-19”. Results Risks of developing severe COVID-19 in children escalate with increasing numbers of co-morbidities and an unvaccinated status. Acute respiratory distress stress and necrotizing pneumonia are prominent pulmonary manifestations, while various forms of cardiovascular and neurological involvement may also be seen. Multiple immunological processes are implicated in the host response to COVID-19 including the type I interferon and inflammasome pathways, whose dysregulation in severe and critical diseases translates into adverse clinical manifestations. Multisystem inflammatory syndrome in children (MIS-C), a potentially life-threatening immune-mediated condition chronologically associated with COVID-19 exposure, denotes another scientific and clinical conundrum that exemplifies the complexity of pediatric immunity. Despite the considerable dissimilarities between the pediatric and adult immune systems, clinical trials dedicated to children are lacking and current management recommendations are largely adapted from adult guidelines. Conclusions Severe pediatric COVID-19 can affect multiple organ systems. The dysregulated immune pathways in severe COVID-19 shape the disease course, epitomize the vast functional diversity of the pediatric immune system and highlight the immunophenotypical differences between children and adults. Consequently, further research may be warranted to adequately address them in pediatric-specific clinical practice guidelines.
Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis

Jae Hong Choi,Soo-Han Choi,Ki Wook Yun

DOI: https://doi.org/10.3346/jkms.2022.37.e35

2022-01-01

Journal of Korean Medical Science

Abstract:BACKGROUND: Coronavirus disease 2019 (COVID-19) has been the most important global issue since December 2019. Although the clinical course of COVID-19 is known to be milder in children than in adults, associated hospitalizations among children have increased since the emergence of contagious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and the achievement of a high vaccination rate in adults. Considering these global and domestic situations, we believe that risk stratification in children with COVID-19 is urgently needed for decision making regarding hospitalization priority in children infected with SARS-CoV-2 and vaccination priority against COVID-19.METHODS: This systematic review and meta-analysis was performed by comprehensively searching the PubMed, EMBASE, Scopus and KoreaMed databases through August 25, 2021. The criteria for enrollment were "severe COVID-19" as poor outcomes (intensive care unit admission, invasive mechanical ventilation, and/or death) and underlying comorbidities before SARS-CoV-2 infection.RESULTS: Among 872 screened studies, 17 articles were included in the systematic review, and 10 articles were included in the meta-analysis. Neonate (risk ratio [RR], 2.69; 95% confidence interval [CI], 1.83-3.97), prematurity in young infants (RR, 2.00; 95% CI, 1.63-2.46), obesity (RR, 1.43; 95% CI, 1.24-1.64), diabetes (RR, 2.26; 95% CI, 1.95-2.62), chronic lung disease (RR, 2.62; 95% CI, 1.71-4.00), heart disease (RR, 1.82; 95% CI, 1.58-2.09), neurologic disease (RR, 1.18; 95% CI, 1.05-1.33), and immunocompromised status (RR, 1.44; 95% CI, 1.01-2.04) were significant risk factors for severe COVID-19 in children. In the subgroup analysis, age younger than 3 months (RR, 0.26; 95% CI, 0.11-0.66), asthma (RR, 1.08; 95% CI, 0.98-1.20), and neurodevelopmental disorders (RR, 0.88; 95% CI, 0.75-1.04) were not risk factors for severe COVID-19.CONCLUSION: Children with comorbidities such as obesity, diabetes, heart disease, chronic lung diseases other than asthma, seizure disorders, and an immunocompromised status had a high prevalence of severe COVID-19. Neonate and premature infants had a high risk of severe COVID-19. Defining the high-risk group for severe COVID-19 could help to guide hospital admission and priority for vaccination against SARS-CoV-2.

medicine, general & internal
The communicative aspect of nonfatal suicidal behavior--are there gender differences?

H. Hjelmeland,B. Knizek,H. Nordvik

DOI: https://doi.org/10.1027//0227-5910.23.4.144

2002-12-01

Crisis

Abstract:Data from the Norwegian part of the WHO/EURO Multicenter Study on Suicidal Behavior were used to investigate gender differences in the communicative aspect of nonfatal suicidal behavior by means of analyzing precipitating factors, intentions involved in and effects of the suicidal act within the frame of Qvortrup's interpretation of speech-act theory. Eighty-nine patients (48 women and 41 men) were included in the analyses, virtually no gender differences were found. Thus, in general, the results did not support the view that persons engaging in nonfatal suicidal behavior should receive different treatment or follow-up as a group based on their gender. The results gave some support to Qvortrup's speech-act theory and his four categories of suicidal behavior, emotional toward others, regulative toward others, emotional toward oneself and regulative toward oneself.
Characteristics of children admitted to hospital with acute SARS-CoV-2 infection in Canada in 2020

Olivier Drouin,Charlotte Moore Hepburn,Daniel S Farrar,Krista Baerg,Kevin Chan,Claude Cyr,Elizabeth J Donner,Joanne E Embree,Catherine Farrell,Sarah Forgie,Ryan Giroux,Kristopher T Kang,Melanie King,Melanie Laffin,Thuy Mai Luu,Julia Orkin,Jesse Papenburg,Catherine M Pound,Victoria E Price,Rupeena Purewal,Manish Sadarangani,Marina I Salvadori,Karina A Top,Isabelle Viel-Thériault,Fatima Kakkar,Shaun K Morris,Canadian Paediatric Surveillance Program COVID-19 Study Team

DOI: https://doi.org/10.1503/cmaj.210053

2021-09-27

CMAJ

Abstract:Background: Risk factors for severe outcomes of SARS-CoV-2 infection are not well established in children. We sought to describe pediatric hospital admissions associated with SARS-CoV-2 infection in Canada and identify risk factors for more severe disease. Methods: We conducted a national prospective study using the infrastructure of the Canadian Paediatric Surveillance Program (CPSP). Cases involving children who were admitted to hospital with microbiologically confirmed SARS-CoV-2 infection were reported from Apr. 8 to Dec. 31 2020, through weekly online questionnaires distributed to the CPSP network of more than 2800 pediatricians. We categorized hospital admissions as related to COVID-19, incidental, or for social or infection control reasons and determined risk factors for disease severity in hospital. Results: Among 264 hospital admissions involving children with SARS-CoV-2 infection during the 9-month study period, 150 (56.8%) admissions were related to COVID-19 and 100 (37.9%) were incidental infections (admissions for other reasons and found to be positive for SARS-CoV-2 on screening). Infants (37.3%) and adolescents (29.6%) represented most cases. Among hospital admissions related to COVID-19, 52 (34.7%) had critical disease, 42 (28.0%) of whom required any form of respiratory or hemodynamic support, and 59 (39.3%) had at least 1 underlying comorbidity. Children with obesity, chronic neurologic conditions or chronic lung disease other than asthma were more likely to have severe or critical COVID-19. Interpretation: Among children who were admitted to hospital with SARS-CoV-2 infection in Canada during the early COVID-19 pandemic period, incidental SARS-CoV-2 infection was common. In children admitted with acute COVID-19, obesity and neurologic and respiratory comorbidities were associated with more severe disease.
Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022

Kristin J. Marks,Michael Whitaker,Nickolas T. Agathis,Onika Anglin,Jennifer Milucky,Kadam Patel,Huong Pham,Pam Daily Kirley,Breanna Kawasaki,James Meek,Evan J. Anderson,Andy Weigel,Sue Kim,Ruth Lynfield,Susan L. Ropp,Nancy L. Spina,Nancy M. Bennett,Eli Shiltz,Melissa Sutton,H. Keipp Talbot,Andrea Price,Christopher A. Taylor,Fiona P. Havers,Jeremy Roland,Jordan Surgnier,Carol Lyons,Kyle Openo,Kenzie Teno,Alexander Kohrman,Erica Bye,Cory Cline,Alison Muse,Virginia Cafferky,Laurie Billing,Nasreen Abdullah,William Schaffner,Keegan McCaffrey,,

DOI: https://doi.org/10.15585/mmwr.mm7111e2

2022-03-18

Abstract:The B.1.1.529 (Omicron) variant of SARS-CoV-2, the virus that causes COVID-19, has been the predominant circulating variant in the United States since late December 2021.* Coinciding with increased Omicron circulation, COVID-19-associated hospitalization rates increased rapidly among infants and children aged 0-4 years, a group not yet eligible for vaccination (1). Coronavirus Disease 19-Associated Hospitalization Surveillance Network (COVID-NET)<sup>†</sup> data were analyzed to describe COVID-19-associated hospitalizations among U.S. infants and children aged 0-4 years since March 2020. During the period of Omicron predominance (December 19, 2021-February 19, 2022), weekly COVID-19-associated hospitalization rates per 100,000 infants and children aged 0-4 years peaked at 14.5 (week ending January 8, 2022); this Omicron-predominant period peak was approximately five times that during the period of SARS-CoV-2 B.1.617.2 (Delta) predominance (June 27-December 18, 2021, which peaked the week ending September 11, 2021).<sup>§</sup> During Omicron predominance, 63% of hospitalized infants and children had no underlying medical conditions; infants aged <6 months accounted for 44% of hospitalizations, although no differences were observed in indicators of severity by age. Strategies to prevent COVID-19 among infants and young children are important and include vaccination among currently eligible populations (2) such as pregnant women (3), family members, and caregivers of infants and young children (4).
Clinical characteristics and factors associated with severe COVID-19 in hospitalized children during the SARS-CoV-2 Omicron pandemic in Taiwan

Song-Ming Huang,Chi-Hsien Wu,Ting-Yu Yen,En-Ting Wu,Ching-Chia Wang,Frank Leigh Lu,Chun-Yi Lu,Jong-Min Chen,Ping-Ing Lee,Wang-Tso Lee,Luan-Yin Chang,Li-Min Huang

DOI: https://doi.org/10.1016/j.jmii.2023.06.001

2023-06-19

Abstract:Background Since April 2022, a notable increase in COVID-19 cases with the rapid spread of the SARS-CoV-2 Omicron variant has been reported in Taiwan. In the epidemic, children were one of the most vulnerable groups, so we analyzed their clinical presentations and factors associated with severe complications of COVID-19 in children. Methods We included hospitalized patients under 18 years old with lab-confirmed SARS-CoV-2 infection from March 1, 2022, to July 31, 2022. We collected the demographic and clinical characteristics of the patients. Patients requiring intensive care were defined as severe cases. Results Among the 339 enrolled patients, the median age was 31 months (interquartile range (IQR), 8– 79.0 months); and 96 patients ( 28.3 %) had underlying diseases. Fever was noted in 319 patients ( 94.1 %) with a median duration of two days (IQR 2–3 days). Twenty-two patients (6.5%) were severe cases, including 10 patients (2.9%) with encephalopathy with abnormal neuroimaging and ten patients ( 2.9 %) with shock. Two patients (0.6%) died. Patients with congenital cardiovascular disease (aOR: 21.689), duration of fever up to four days or more (aOR: 6.466), desaturation (aOR: 16.081), seizure (aOR: 20.92), and procalcitonin >0.5 ng/mL (aOR: 7.886) had a higher risk of severe COVID-19. Conclusions Vital signs need close monitoring, early management and/or intensive care may be applied in COVID-19 patients with congenital cardiovascular diseases, fever lasting ≥4 days, seizures, desaturation and/or elevated procalcition since they are at higher risks of severe diseases.

immunology,infectious diseases,microbiology
Related Factors for Severe, Critical and Death in Children with Healthcare-Associated COVID-19

F Ortega-Riosvelasco,R Moreno-Miranda,V E López-Moreno,S A Estrada-Chacón,F J Prado-Galbarro,P A Mejía-Rosales,D de la Rosa-Zamboni,A E Gamiño-Arroyo

DOI: https://doi.org/10.1093/jpids/piad070.038

2023-11-01

Journal of the Pediatric Infectious Diseases Society

Abstract:Abstract Background Since the beginning of the pandemic, the American Academy of Pediatrics and the Children′s Hospital Association have reported over 15.4 million cases of COVID-19 in children in the United States (18% of all cases).1 UNICEF on the other hand, has reported more than 288 million cases all over the world and 4.1 million deaths related to COVID-19 in children.2 Healthcare-Associated Infections (HAI) represent a big burden on the health care system, with a subsequent increase in morbidity, hospital stay, medication/procedures, intensive care unit admissions, mortality, etc. Globally there is not enough data of HAI for SARS-CoV-2 in children, specially from low and lower-middle income countries. Methods Prognosis study through the description and analysis of an ambispective cohort in children at a tertiary care pediatric hospital [Hospital Infantil de Mexico Federico Gomez: (HIMFG)] in Mexico City from April 2020 to December 2022. We identified patients <18 years old with probable and definite healthcare-associated (HA) COVID-19 according to the CDC definition:3 symptom onset (or positive test) on day 8 or on, after admission. Independent variables included socio-demographic information, clinical symptoms, laboratory results, among others. Outcome variables measured included severity (severe and critical), and death.4 Chi square and Wilcoxon tests were performed to identify independent risk factors for severity and death. After the bivariate analysis, logistic regression models were used to identify factors associated with patient severity and mortality. Results 102 patients were included; mean age was 6.4 years (min 0.02, max 17.9) and 57 were male. 32 were asymptomatic, 27 had mild disease, 6 were moderate, 31 severe and 6 critical; of this total, 6 patients died. 98 patients had at least one comorbidity, and 54 had at least 2: 35 with immunosuppression, 28 with cancer, 18 with heart disease, 14 with pulmonary disease and 14 with neurologic disease. 14 patients required admission to a Pediatric Intensive Care Unit. Mean hospital stay at diagnosis was 35.5 days (min 8, max 143): 24 patients were identified with probable HA-COVID-19 (8-14 days after admission) and 78 with definite HA-COVID-19 (>14 days after admission). Conclusions Since the beginning of the COVID-19 pandemic, multiple strategies in infection prevention and control have been implemented at our hospital: universal screening before admission, active surveillance for patients/caretakers/health-care workers with respiratory symptoms and for contacts, universal use of facemasks, isolation of patients with respiratory symptoms, among others. Despite all these measures, a free Hospital from HA-COVID-19 remains a challenge. Our study found that the sudden onset of symptoms, the presence of fever, irritability and polypnea increases significantly the risk for severity in patients that acquired the disease in the hospital. On the other hand, patients with an underlying heart disease have 30 times more risk of dying than those who doesn’t. The presence of O2 desaturation and admission to a PICU increases significantly the mortality in patients with HA-COVID-19. Overall, mortality in children with HA-COVID-19 was 5.9% (up to 8.6% if strictly considering only the symptomatic), much more that the one reported globally (1.4%).2 References 1. Cull B HMBLRG. Children and COVID-19 State Date Report. American Academy of Pediatrics. 2022;V. 10/6/22. 2. UNICEF DATA. UNICEF [cited 2022 Oct] Available from: COVID-19 confirmed cases and deaths - UNICEF DATA. 3. Surveillance definitions for COVID-19. European Centre for Disease Prevention and Control. 2021 Mar 21 https://www.ecdc.europa.eu/en/covid-19/surveillance/surveillance-definitions 4. COVID-19. OMS. Enero 2021: Manejo Clínico de la COVID-19. Orientaciones evolutivas; 25 de Enero de 2021. OMS reference number: WHO/2019-nCoV/clinical/2021.1)

pediatrics,infectious diseases
Severe acute respiratory syndrome coronavirus 2 infection rate among pediatric patients with respiratory symptoms

Penpitcha Samerton,Nopporn Apiwattanakul,Surapat Assawawiroonhakarn,Thiantip Sahakijpicharn,Rakruthai Thongchai,Chonnamet Techasaensiri,Sophida Boonsathorn,Sujittra Chaisavaneeyakorn

DOI: https://doi.org/10.1111/ped.15740

2024-04-22

Pediatrics International

Abstract:Background The incidence of coronavirus disease 2019 (COVID‐19) in children has been increasing worldwide since the onset of the pandemic. This study examined the risk factors and characteristics of COVID‐19 among pediatric patients compared to other respiratory viral infections. Methods This was a prospective cross‐sectional study. Patients aged 0–18 years presenting with respiratory symptoms from October 2020 to December 2021 were included. Demographic and clinical data were reviewed. Results In total, 738 pediatric patients were enrolled. Of these, 48.5% had COVID‐19, and 41.3% were infected with another respiratory virus. The COVID‐19 incidence increased from 0.5% during the original strain outbreak (October 2020 to March 2021) to 56.5% and 73.4% during the alpha (April to June 2021) and delta (July to December 2021) periods, respectively. Children aged 6‐18 years, being female, obesity, exposure to household members with COVID‐19, and the delta period were risk factors for COVID‐19. Being aged 1‐5 years, obesity, shortness of breath, productive cough, and chest pain were associated with COVID‐19 pneumonia. Children aged 5–18 years, underlying neurological disease, a history of COVID‐19 pneumonia, and the delta period were associated with long COVID. Conclusions Pediatric COVID‐19 patients presenting with respiratory symptoms who are obese or have been exposed to household members with COVID‐19 should be tested for COVID‐19. COVID‐19 patients who are obese, younger than five years old, or who present with shortness of breath, productive cough, or chest pain should be evaluated for pneumonia. COVID‐19 patients with a history of COVID‐19 pneumonia or underlying neurological disease should receive follow‐up for long COVID.

pediatrics
Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study

Dan Sun,Hui Li,Xiao-Xia Lu,Han Xiao,Jie Ren,Fu-Rong Zhang,Zhi-Sheng Liu

DOI: https://doi.org/10.1007/s12519-020-00354-4

2020-01-01

World Journal of Pediatrics

Abstract:Background An outbreak of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was first detected in Wuhan, Hubei, China. People of all ages are susceptible to SARS-CoV-2 infection. No information on severe pediatric patients with COVID-19 has been reported. We aimed to describe the clinical features of severe pediatric patients with COVID-19. Methods We included eight severe or critically ill patients with COVID-19 who were treated at the Intensive Care Unit (ICU), Wuhan Children’s Hospital from January 24 to February 24. We collected information including demographic data, symptoms, imaging data, laboratory findings, treatments and clinical outcomes of the patients with severe COVID-19. Results The onset age of the eight patients ranged from 2 months to 15 years; six were boys. The most common symptoms were polypnea (8/8), followed by fever (6/8) and cough (6/8). Chest imaging showed multiple patch-like shadows in seven patients and ground-glass opacity in six. Laboratory findings revealed normal or increased whole blood counts (7/8), increased C-reactive protein, procalcitonin and lactate dehydrogenase (6/8), and abnormal liver function (4/8). Other findings included decreased CD16 + CD56 (4/8) and Th/Ts*(1/8), increased CD3 (2/8), CD4 (4/8) and CD8 (1/8), IL-6 (2/8), IL-10 (5/8) and IFN-γ (2/8). Treatment modalities were focused on symptomatic and respiratory support. Two critically ill patients underwent invasive mechanical ventilation. Up to February 24, 2020, three patients remained under treatment in ICU, the other five recovered and were discharged home. Conclusions In this series of severe pediatric patients in Wuhan, polypnea was the most common symptom, followed by fever and cough. Common imaging changes included multiple patch-like shadows and ground-glass opacity; and a cytokine storm was found in these patients, which appeared more serious in critically ill patients.
Childhood COVID-19: a Multicentre Retrospective Study

Z. Chen,L. Tong,Y. Zhou,C. Hua,W. Wang,J. Fu,Q. Shu,L. Hong,H. Xu,Z. Xu,Y. Chen,Y. Mao,S. Ye,X. Wu,L. Wang,Y. Luo,X. Zou,X. Tao,Y. Zhang

DOI: https://doi.org/10.1016/j.cmi.2020.06.015

IF: 13.31

2020-01-01

Clinical Microbiology and Infection

Abstract:Objectives: To investigate the clinical and epidemiological characteristics of paediatric patients with coronavirus disease-19 (COVID-19). Methods: Paediatric patients diagnosed with COVID-19 between January 15 and March 15, 2020, from seven hospitals in Zhejiang Province, China, were collected retrospectively and analysed. Results: Thirty-two children with COVID-19, ranging in age from 3 months to 18 years, were enrolled. Family aggregation occurred in 87.5% of infant and preschool-aged children (7/8), and also school-aged children (14/16), but in only 12.5% (1/8) of adolescents (p < 0.05, p < 0.001). Most of these patients had mild symptoms: mainly fever (20/32) followed by cough (10/32) and fatigue (4/32). The average durations of viral RNA in respiratory samples and gastrointestinal samples were 15.8 d and 28.9 d, respectively. Detox duration in faeces decreased with age: 39.8 d, 27.5 d and 20.4 d in infants and preschool children, school children, and adolescents respectively (p(0-6,) (-18) <0.01, p(0-6, -14) <0.05). Pneumonia was found in 14 children, but there was no statistical significance in the incidence of pneumonia between different age groups. Thirty patients were treated with antiviral drugs, and all patients were stable and gradually improved after admission. Conclusions: Most children with COVID-19 had a mild process and a good prognosis. More attention should be paid to investigation of household contact history in the diagnosis of COVID-19 in young children. Viral RNA lasts longer in the gastrointestinal system than in the respiratory tract, especially in younger children. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
Children Hospitalized with Severe COVID-19 in Wuhan

Yanli Wang,Feng Zhu,Cheng Wang,Jing Wu,Jie Liu,Xue Chen,Han Xiao,Zhisheng Liu,Zubo Wu,Xiaoxia Lu,Jiehui Ma,Ye Zeng,Hua Peng,Dan Sun

DOI: https://doi.org/10.1097/inf.0000000000002739

2020-01-01

Abstract:Background: Novel coronavirus disease (COVID-19) is spreading globally. Little is known about the risk factors for the clinical outcomes of COVID-19 in children. Methods: A retrospective case-control study was taken in children with severe acute respiratory syndrome coronary virus-2 infection in Wuhan Children's Hospital. Risk factors associated with the development of COVID-19 and progression were collected and analyzed. Results: Eight of 260 children diagnosed with severe COVID-19 pneumonia were included in the study. Thirty-five children with COVID-19 infection matched for age, sex and date of admission, and who classified as non-severe type, were randomly selected from the hospital admissions. For cases with severe pneumonia caused by COVID-19, the most common symptoms were dyspnea (87.5%), fever (62.5%) and cough (62.5%). In laboratory, white blood cells count was significantly higher in severe children than non-severe children. Levels of inflammation bio-makers such as hsCRP, IL-6, IL-10 and D-dimer elevated in severe children compared with non-severe children on admission. The level of total bilirubin and uric acid clearly elevated in severe children compared with non-severe children on admission. All of severe children displayed the lesions on chest CT, more lung segments were involved in severe children than in non-severe children, which was only risk factor associated with severe COVID-19 pneumonia in multivariable analysis. Conclusions: More than 3 lung segments involved were associated with greater risk of development of severe COVID-19 in children. Moreover, the possible risk of the elevation of IL-6, high total bilirubin and D-dimer with univariable analysis could identify patients to be severe earlier.
Risk Factors for Severe COVID‐19 Among Children and Adolescents Enrolled in Acute Respiratory Infection Sentinel Surveillance in South Africa, 2020–2022

Kate Bishop,Susan Meiring,Stefano Tempia,Anne von Gottberg,Nicole Wolter,Jackie Kleynhans,Fahima Moosa,Mignon du Plessis,Jocelyn Moyes,Mvuyo Makhasi,Boitumelo Chuene,Aaron M. Samuels,Halima Dawood,Gary Reubenson,Heather J. Zar,Vanessa Quan,Cheryl Cohen,Sibongile Walaza

DOI: https://doi.org/10.1111/irv.13300

2024-04-28

Influenza and Other Respiratory Viruses

Abstract:Background Identifying children at risk for severe COVID‐19 disease from severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) may guide future mitigation interventions. Using sentinel surveillance data, we aimed to identify risk factors for SARS‐CoV‐2–associated hospitalisation among patients aged ≤ 18 years with respiratory illness. Methods From April 2020 to March 2022, patients meeting study case definitions were enrolled at four outpatient influenza‐like illness (ILI) and five inpatient severe respiratory infection (SRI) surveillance sites and tested for SARS‐CoV‐2 infection using polymerase chain reaction (PCR). Each ILI clinic shared a catchment area with its corresponding SRI hospital. Potential risk factors for SARS‐CoV‐2–associated hospitalisation were analysed using multivariable logistic regression by comparing inpatient versus outpatient SARS‐CoV‐2 cases. Results Of 4688 participants aged ≤ 18 years, 4556 (97%) with complete PCR and HIV data were included in the analysis. Among patients with ILI and SRI, 92/1145 (8%) and 154/3411 (5%) tested SARS‐CoV‐2 positive, respectively. Compared to outpatients, hospitalised SARS‐CoV‐2 cases were associated with age

infectious diseases,virology
SARS-CoV-2 infection in children: A 24 months experience with focus on risk factors in a pediatric tertiary care hospital in Milan, Italy

Giada Maria Di Pietro,Luisa Ronzoni,Lorenzo Maria Meschia,Claudia Tagliabue,Angela Lombardi,Raffaella Pinzani,Samantha Bosis,Paola Giovanna Marchisio,Luca Valenti

DOI: https://doi.org/10.3389/fped.2023.1082083

IF: 3.569

2023-02-18

Frontiers in Pediatrics

Abstract:Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children is characterized by a wide variety of expressions ranging from asymptomatic to, rarely, critical illness. The basis of this variability is not yet fully understood. The aim of this study was to identify clinical and genetic risk factors predisposing to disease susceptibility and progression in children. Methods: We enrolled 181 consecutive children aged less than 18 years hospitalized with or for SARS-CoV-2 infection during a period of 24 months. Demographic, clinical, laboratory, and microbiological data were collected. The development of coronavirus disease 2019 (COVID-19)-related complications and their specific therapies were assessed. In a subset of 79 children, a genetic analysis was carried out to evaluate the role of common COVID-19 genetic risk factors (chromosome 3 cluster; ABO -blood group system; FUT2 , IFNAR2 , OAS1/2/3 , and DPP9 loci). Results: The mean age of hospitalized children was 5.7 years, 30.9% of them being under 1 year of age. The majority of children (63%) were hospitalized for reasons different than COVID-19 and incidentally tested positive for SARS-CoV-2, while 37% were admitted for SARS-CoV-2 infection. Chronic underlying diseases were reported in 29.8% of children. The majority of children were asymptomatic or mildly symptomatic; only 12.7% developed a moderate to critical disease. A concomitant pathogen, mainly respiratory viruses, was isolated in 53.3%. Complications were reported in 7% of children admitted for other reasons and in 28.3% of those hospitalized for COVID-19. The respiratory system was most frequently involved, and the C-reactive protein was the laboratory test most related to the development of critical clinical complications. The main risk factors for complication development were prematurity [relative risk (RR) 3.8, 95% confidence interval (CI) 2.4–6.1], comorbidities (RR 4.5, 95% CI 3.3–5.6), and the presence of coinfections (RR 2.5, 95% CI 1.1–5.75). The OAS1/2/3 risk variant was the main genetic risk factor for pneumonia development [Odds ratio (OR) 3.28, 95% CI 1-10.7; p value 0.049]. Conclusion: Our study confirmed that COVID-19 is generally less severe in children, although complications can develop, especially in those with comorbidities (chronic diseases or prematurity) and coinfections. Variation at the OAS1/2/3 genes cluster is the main genetic risk factor predisposing to COVID-19 pneumonia in children.

pediatrics
COVID-19 in 7780 pediatric patients: A systematic review

Ansel Hoang,Kevin Chorath,Axel Moreira,Mary Evans,Finn Burmeister-Morton,Fiona Burmeister,Rija Naqvi,Matthew Petershack,Alvaro Moreira

DOI: https://doi.org/10.1016/j.eclinm.2020.100433

IF: 15.1

2020-06-26

EClinicalMedicine

Abstract:Background: Studies summarizing the clinical picture of COVID-19 in children are lacking. This review characterizes clinical symptoms, laboratory, and imaging findings, as well as therapies provided to confirmed pediatric cases of COVID-19. Methods: Adhering to PRISMA guidelines, we searched four medical databases (PubMed, LitCovid, Scopus, WHO COVID-19 database) between December 1, 2019 to May 14, 2020 using the keywords "novel coronavirus", "COVID-19" or "SARS-CoV-2". We included published or in press peer-reviewed cross-sectional, case series, and case reports providing clinical signs, imaging findings, and/or laboratory results of pediatric patients who were positive for COVID-19. Risk of bias was appraised through the quality assessment tool published by the National Institutes of Health. PROSPERO registration # CRD42020182261. Findings: We identified 131 studies across 26 countries comprising 7780 pediatric patients. Although fever (59·1%) and cough (55·9%) were the most frequent symptoms 19·3% of children were asymptomatic. Patchy lesions (21·0%) and ground-glass opacities (32·9%) depicted lung radiograph and computed tomography findings, respectively. Immunocompromised children or those with respiratory/cardiac disease comprised the largest subset of COVID-19 children with underlying medical conditions (152 of 233 individuals). Coinfections were observed in 5.6% of children and abnormal laboratory markers included serum D-dimer, procalcitonin, creatine kinase, and interleukin-6. Seven deaths were reported (0·09%) and 11 children (0·14%) met inclusion for multisystem inflammatory syndrome in children. Interpretation: This review provides evidence that children diagnosed with COVID-19 have an overall excellent prognosis. Future longitudinal studies are needed to confirm our findings and better understand which patients are at increased risk for developing severe inflammation and multiorgan failure. Funding: Parker B. Francis and pilot grant from 2R25-HL126140. Funding agencies had no involvement in the study.
SARS-CoV-2 With Concurrent Respiratory Viral Infection as a Risk Factor for a Higher Level of Care in Hospitalized Pediatric Patients

Lea Dikranian,Suzanne Barry,Ashar Ata,Katie Chiotos,Katja Gist,Utpal Bhalala,Valerie Danesh,Smitty Heavner,Varsha Gharpure,Erica C Bjornstad,Olivia Irby,Julia A Heneghan,Vicki Montgomery,Neha Gupta,Aaron Miller,Allan Walkey,Sandeep Tripathi,Karen Boman,Vikas Bansal,Vishakha Kumar,Rahul Kashyap,Imran Sayed,Christopher Woll,From the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study: COVID-19 Registry Investigator Group

DOI: https://doi.org/10.1097/PEC.0000000000002814

2022-09-01

Abstract:Objective: As of early 2021, there have been over 3.5 million pediatric cases of SARS-CoV-2, including 292 pediatric deaths in the United States. Although most pediatric patients present with mild disease, they are still at risk for developing significant morbidity requiring hospitalization and intensive care unit (ICU) level of care. This study was performed to evaluate if the presence of concurrent respiratory viral infections in pediatric patients admitted to the hospital with SARS-CoV-2 was associated with an increased rate of ICU level of care. Design: A multicenter, international, noninterventional, cross-sectional study using data provided through The Society of Critical Care Medicine Discovery Network Viral Infection and Respiratory Illness Universal Study database. Setting: The medical ward and ICU of 67 participating hospitals. Patients: Pediatric patients younger than 18 years hospitalized with SARS-CoV-2. Interventions: None. Measurements and main results: A total of 922 patients were included. Among these patients, 391 required ICU level care and 31 had concurrent non-SARS-CoV-2 viral coinfection. In a multivariate analysis, after accounting for age, positive blood culture, positive sputum culture, preexisting chronic medical conditions, the presence of a viral respiratory coinfection was associated with need for ICU care (odds ratio, 3.6; 95% confidence interval, 1.6-9.4; P < 0.01). Conclusions: This study demonstrates an association between concurrent SARS-CoV-2 infection with viral respiratory coinfection and the need for ICU care. Further research is needed to identify other risk factors that can be used to derive and validate a risk-stratification tool for disease severity in pediatric patients with SARS-CoV-2.
A cross-sectional study on clinical characteristics and severity of children with COVID-19 admitted to a teaching institute in North India

Deepty Nauriyal,Rishabh Dubey,Pulak Agrawal,Deepak Kumar,Ajay Punj,Kaynat Nasser

DOI: https://doi.org/10.4103/jfmpc.jfmpc_1734_23

Abstract:Background: SARS-CoV-2 infection presentation in children is usually milder than in adults but can be severe and fatal as well. Data on the pediatric population regarding severity and clinical presentation are still limited, and there is a need to have a better understanding of clinical features, severity, and laboratory parameters. Aims and objective: To document clinical and laboratory characteristics and outcomes of children with SARS-CoV-2 in a low-middle-income country and to evaluate clinicodemographic factors and biochemical markers associated with severity and mortality. Materials and methods: A hospital-based cross-sectional study was conducted among 112 COVID-19-positive children at a designated Level-3 center in North India. Clinical characteristics, laboratory parameters, and severity of COVID-19 cases as well as factors associated with the severity of the disease, were analyzed by descriptive statistics and a Chi-square test. Results: The adolescent age group (age 12-18 years) was affected most (64.3%). Male patients accounted for 56.3% of total cases. Fever was the most common symptom (41.1%) followed by cough. Presenting complaints were highest from the respiratory system (32.1%) followed by the gastrointestinal (8.9%) and the neurological system (7.1%). Majority of patients had mild disease (87%) while 13% had the moderate-severe disease. Spo2 < 95% (P = 0.00001), neutrophilia (P < 0.000001), lymphopenia (P < 0.000001), elevated values of C-reactive protein (P < 0.00001), Interleukin-6 (P = 0.002), D- dimer (P = 0.00014) and respiratory symptoms as presenting complaints (P < 0.000001) were found to be significantly associated with severity of disease. Conclusion: The male and adolescent age group was affected most. Presenting complaints were highest from the respiratory system. Unusual presentation may have gastrointestinal or neurological presentation. Most children with COVID-19 had mild disease. Moderate to severe disease was not uncommon. Factors including neutrophilia, lymphopenia, elevated lab values of C-reactive protein, D-dimer, and interleukin-6 had a significant association with the severity of the disease. These biomarkers can help predict the severity of the disease.
The Role of Childhood Obesity in Acute Presentations and Outcomes of Hospitalized COVID-19 Patients

Tyler Tolopka,Joshua Kuehne,Kiran Mainali,Morgan Beebe,Melinda Garcia,Mohammed Salameh,Rosario Ocampo,Utpal Bhalala

DOI: https://doi.org/10.7759/cureus.28911

2022-09-07

Cureus

Abstract:Background and objective The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has affected all regions, demographics, and age groups worldwide. However, few studies have investigated the prevalence of childhood obesity and severe COVID-19 presentation in a predominately Hispanic population. In light of this, we investigated the role of underlying obesity in COVID-19 presentations and outcomes at a tertiary care children's hospital by using subcategories based on patients' body mass index (BMI). Methods We conducted a single-center retrospective study involving 77 pediatric patients aged 18 years and younger, who were hospitalized with suspected or verified COVID-19 between February 2020 and January 2021. We collected data on height, weight, and BMI and categorized patients based on the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) definition(s) of obesity. We also collected data on demographics, mode of presentation, need for pediatric intensive care unit (PICU) admission, the severity of illness at the time of PICU admission, and data related to outcomes. We analyzed the data using logistical regression with Firth's biased reduction method wherever applicable. Results In our cohort, over 85% of the patients identified as belonging to Hispanic ethnicity (n=66); the median age of the cohort was 8.69 years, and 50.65% were classified as obese (n=39). We found a statistically significant relationship between underlying obesity and one or more comorbidities (p<0.001). BMI classification was significantly dependent on the incidence of multisystem inflammatory syndrome in children (MIS-C) (p=0.0353). Furthermore, the bivariate analysis confirmed that acute kidney injury (AKI) (p=0.048) and MIS-C predictors (p<0.001) were significantly associated with PICU admission status. The combined model confirmed a significant relationship between MIS-C and both PICU admission status (p<0.001) and obese BMI classification (p=0.002). PICU admission status led to increased hospital length of stay (LOS) (p<0.001). Patient age (p=0.003), underweight BMI (p=0.034), and obese BMI (P=0.008) were significant predictors of PICU LOS. Of note, the survival rate among admitted COVID-19 patients was 93.5%. Conclusion Based on our findings on the prevalence of underlying obesity in admitted COVID-19 patients at the Children's Hospital of San Antonio, over 50% of pediatric patients were obese and predominately Hispanic. Obesity was significantly associated with patient age, comorbidities, MIS-C status, and PICU LOS. Hospital mortality in pediatric COVID-19 patients was low (6.49%) and consistent with other studies in the literature showing lower rates of mortality in children versus mortality in adult patients with COVID-19.

Quiz questions. Idiopathic leukoplakia, tobacoco-induced leukoplakia, frictional keratosis, plaque lichen planus, candidal leukoplakia (chronic hyperplastic leukoplakia), squamous cell carcinoma, lichenoid reaction to drug or amalgam, or oral hairy leukoplakia.

Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children

Clinical Features and Outcomes of Pediatric and Adult Patients Hospitalized for Coronavirus Disease 2019: A Comparison Across Age Strata

Educational strategies for overcoming health care disparities

Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives

Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis

The communicative aspect of nonfatal suicidal behavior--are there gender differences?

Characteristics of children admitted to hospital with acute SARS-CoV-2 infection in Canada in 2020

Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022

Clinical characteristics and factors associated with severe COVID-19 in hospitalized children during the SARS-CoV-2 Omicron pandemic in Taiwan

Related Factors for Severe, Critical and Death in Children with Healthcare-Associated COVID-19

Severe acute respiratory syndrome coronavirus 2 infection rate among pediatric patients with respiratory symptoms

Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study

Childhood COVID-19: a Multicentre Retrospective Study

Children Hospitalized with Severe COVID-19 in Wuhan

Risk Factors for Severe COVID‐19 Among Children and Adolescents Enrolled in Acute Respiratory Infection Sentinel Surveillance in South Africa, 2020–2022

SARS-CoV-2 infection in children: A 24 months experience with focus on risk factors in a pediatric tertiary care hospital in Milan, Italy

COVID-19 in 7780 pediatric patients: A systematic review

SARS-CoV-2 With Concurrent Respiratory Viral Infection as a Risk Factor for a Higher Level of Care in Hospitalized Pediatric Patients

A cross-sectional study on clinical characteristics and severity of children with COVID-19 admitted to a teaching institute in North India

The Role of Childhood Obesity in Acute Presentations and Outcomes of Hospitalized COVID-19 Patients